Author:
Sawa Teiji,Kainuma Atsushi,Moriyama Kiyoshi,Naito Yoshifumi
Reference41 articles.
1. Salyers AA, Whitt DD. Pseudomonas aeruginosa. In: Salyers AA, White DD, editors. Bacterial Pathogenesis: A Molecular Approach. Washington, DC: American Society for Microbiology Press; 1994. pp. 260-270
2. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiological Reviews. 1996;60:539-574
3. Ramirez-Estrada S, Borgatta B, Rello J. Pseudomonas aeruginosa ventilator-associated pneumonia management. Infection and Drug Resistance. 2016;9:7-18. DOI: 10.2147/IDR.S50669
4. Grgurich PE, Hudcova J, Lei Y, et al. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens. Expert Review of Respiratory Medicine. 2012;6:533-555. DOI: 10.1586/ers.12.45
5. Kudoh I, Wiener-Kronish JP, Hashimoto S, et al. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. American Journal of Physiology. 1994;267:L551-L556